Advertisement

APEN

Apollo Endosurgery, Inc.

Healthcare

Set alert

Price alert · APEN

All alert types
10.00 0.00 0.00%
As of Apr 3, 2023
9.92 Day range 10.00

52-week range unavailable

Open
9.93
Prev close
10.00
Mkt cap
579.72M
Vol
1.64M
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
9.92
High
10.00
Forward P/E
-11.36
Beta
2.32
Short ratio
0.35
Inst. own
63.41%
Dividend
0.00
Ex-div date
Earnings
May 2, 2023
50-d avg
9.94
200-d avg
7.73
1y target
10.00

2Y chart

Chart tools
Interval

Chart is warming up

The two-year price history for APEN has not been loaded yet. Try again in a moment.

Key statistics

Market cap
579.72M
Enterprise value
579.78M
Trailing P/E
0.00
Forward P/E
-11.36
PEG ratio
0.00
Price / sales
7.54
Price / book
12.89
EPS (TTM)
-1.06
Beta
2.32
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-51.84%
Revenue (TTM)
76.86M
Revenue growth
31.80%
Free cash flow
-19.84M
Total cash
57.00M
Total debt
57.06M
Return on equity
-84.92%
Shares outstanding
47.55M
Short % of float
1.14%
50-day average
9.94
200-day average
7.73

Analyst view

Consensus: buy

Buy
Price target (mean) 10.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
  • Strong buy0
  • Buy2
  • Hold0
  • Sell0
  • Strong sell0

Next earnings

May 2, 2023

Expected May 2, 2023. Consensus EPS estimate -0.21.

Earnings history

Financials — quick view

All financials
APEN Revenue — quarterly 21.31M
2019-Q1 20192019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 2022
APEN Net income — quarterly -9.55M
2019-Q1 20192019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 2022
APEN EPS — quarterly -0.23
2019-Q1 20192019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 2022

Earnings

APEN recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
May 2, 2023Mar 1, 20230.00———
Apr 4, 2023Dec 1, 2022-0.21———
Nov 1, 2022Sep 1, 2022-0.21———
Aug 2, 2022Jun 1, 2022-0.21———
May 3, 2022Mar 1, 2022-0.21———
Feb 22, 2022Dec 1, 2021-0.20———

Upgrades / downgrades

APEN analyst upgrades and downgrades
DateFirmActionFromTo
Jan 23, 2023Cowen & Co.downOutperformMarket Perform
Jan 4, 2023StifeldownBuyHold
Nov 30, 2022Lake StreetdownBuyHold
May 4, 2022Stephens & Co.main—Overweight
Feb 23, 2022Stifelmain—Buy
Dec 15, 2021Cowen & Co.init—Outperform

About Apollo Endosurgery, Inc.

Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices for gastrointestinal therapeutic endoscopy. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to suture and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, and delays gastric content emptying, which assists the patient in losing weight under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands. In addition, the company offers X-Tack Endoscopic HeliX Tacking System, a suture-based device for closing and healing defects in the lower and upper gastrointestinal tract. The company sells its products to medical service providers, hospitals, outpatient surgical centers, clinics, and physicians in the United States, Costa Rica, Australia, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.

Sector
Healthcare
Industry
Medical Devices
Country
United States

News

Your note

Sign in to keep a note on APEN — it syncs with the Stock Master app.

Insider holders

APEN insider holders
InsiderRelationLatest transactionDateShares held
ANDERSON RICK DDirector and Beneficial Owner of more than 10% of a Class of SecurityStock Award(Grant)Jun 13, 2022113,484
BARR JOHN RDirectorStock Award(Grant)Jun 13, 202244,082
BLACK JEFFREY GChief Financial OfficerStock Award(Grant)Jun 13, 2022353,900
CPMG, INC.Beneficial Owner of more than 10% of a Class of SecurityConversion of Exercise of derivative securityDec 27, 20220
MCCLELLAN WILLIAM D JRDirectorStock Award(Grant)Jun 13, 202239,249
MCGAUGHY R KENT JRDirector and Beneficial Owner of more than 10% of a Class of SecurityConversion of Exercise of derivative securityDec 27, 20220

Institution ownership

APEN institution ownership
Holder% heldSharesValueReported
CPMG INC10.67%6,183,60361.84MDec 30, 2022
Nantahala Capital Management, LLC7.00%4,056,62740.57MDec 30, 2022
Stonepine Capital Management, LLC6.43%3,726,58437.27MDec 30, 2022
Citigroup Inc.4.12%2,386,55723.87MDec 30, 2022
Deerfield Management Company, L.P. (Series C)3.02%1,750,00017.50MDec 30, 2022
Gagnon Securities, LLC2.94%1,703,17517.03MDec 30, 2022

Fund ownership

APEN fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund1.84%876,9598.77MSep 29, 2022
Vanguard Extended Market Index Fund0.92%436,9124.37MSep 29, 2022
Arbitrage Fund0.76%359,0003.59MNov 29, 2022
Fidelity Extended Market Index Fund0.39%184,9921.85MNov 29, 2022
Federated Hermes Kaufmann Fund0.28%133,2811.33MOct 30, 2022
Bridgeway Funds Inc-Ultra Small Company Fund0.19%90,800908.00KSep 29, 2022
Advertisement